Decreased tryptophan excretion by depressive patients

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Tryptophan metabolism is implicated in mood disorders.
• Previous research suggests potential alterations in tryptophan pathways in depression.
• Understanding these metabolic differences is crucial for diagnosing and treating depression.

Purpose of the Study:

• To measure tryptophan concentration and 24-hour urinary excretion in female patients with monopolar depression and healthy controls.
• To investigate differences in tryptophan excretion between subtypes of depression (endogenous vs. reactive).
• To explore the relationship between plasma tryptophan and urinary excretion in controls to understand normal metabolism.

Main Methods:

• Collected urine samples from female patients diagnosed with monopolar depression and age-matched female control subjects.
• Measured 24-hour urinary excretion of tryptophan in all participants.
• Analyzed plasma tryptophan concentrations in control subjects.
• Compared tryptophan excretion levels between patient groups and controls.

Main Results:

• No significant difference in 24-hour urinary tryptophan excretion was found between female depressed patients and control subjects.
• Patients with endogenous depression exhibited significantly lower 24-hour urinary tryptophan excretion compared to those with reactive depression and controls.
• A relationship between plasma tryptophan concentration and 24-hour urinary excretion was observed in control subjects.

Conclusions:

• Urinary tryptophan excretion may not differ in overall female depression but is significantly reduced in endogenous depression.
• These findings suggest specific abnormalities in tryptophan metabolism associated with endogenous depressive illness.
• Further research into tryptophan metabolism could offer insights into diagnostic markers and therapeutic targets for depression.